Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011 | Zendy

Michael R. Jordan | Zendy; Diane Bennett | Zendy; Mark A. Wainberg | Zendy; D Havlir | Zendy; S. Hammer | Zendy; Chunfu Yang | Zendy; Lynn Morris | Zendy; Martine Peeters | Zendy; Annemarie M. J. Wensing | Zendy; Neil Parkin | Zendy; Jean B. Nachega | Zendy; Andrew Phillips | Zendy; Andrea De Luca | Zendy; Elvin Geng | Zendy; Alexandra Calmy | Zendy; Elliot Raizes | Zendy; Paul Sandstrom | Zendy; Chris Archibald | Zendy; Joseph H. Perriëns | Zendy; Craig McClure | Zendy; Steven Y. Hong | Zendy; James McMahon | Zendy; Nikos Dedes | Zendy; Donald Sutherland | Zendy; Silvia Bertagnolio | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011

Author(s) -

Michael R. Jordan,

Diane Bennett,

Mark A. Wainberg,

D Havlir,

S. Hammer,

Chunfu Yang,

Lynn Morris,

Martine Peeters,

Annemarie M. J. Wensing,

Neil Parkin,

Jean B. Nachega,

Andrew Phillips,

Andrea De Luca,

Elvin Geng,

Alexandra Calmy,

Elliot Raizes,

Paul Sandstrom,

Chris Archibald,

Joseph H. Perriëns,

Craig McClure,

Steven Y. Hong,

James McMahon,

Nikos Dedes,

Donald Sutherland,

Silvia Bertagnolio

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis206

Subject(s) - hiv drug resistance , medicine , human immunodeficiency virus (hiv) , accreditation , general partnership , drug resistance , transmission (telecommunications) , family medicine , antiretroviral therapy , viral load , medical education , microbiology and biotechnology , computer science , telecommunications , business , biology , finance

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research